These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6132848)

  • 1. Glucagon-induced increase in plasma potassium levels in type 1 (insulin-dependent) diabetic subjects.
    Cagliero E; Martina V; Massara F; Molinatti GM
    Diabetologia; 1983 Feb; 24(2):85-7. PubMed ID: 6132848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of glucagon on plasma levels of potassium in man.
    Massara F; Martelli S; Cagliero E; Camanni F; Molinatti GM
    Diabetologia; 1980 Nov; 19(5):414-7. PubMed ID: 6108887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.
    DeFronzo RA; Sherwin RS; Dillingham M; Hendler R; Tamborlane WV; Felig P
    J Clin Invest; 1978 Feb; 61(2):472-9. PubMed ID: 621284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hyperglucagonaemia on blood glucose concentrations and on insulin requirements during fasting in insulin dependent diabetes mellitus.
    Clarke WL; Melton TW; Bright GM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):557-60. PubMed ID: 6342325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man.
    Massara F; Cagliero E; Maccario M; Orzan F; Carini G
    Miner Electrolyte Metab; 1986; 12(2):142-6. PubMed ID: 2870423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject.
    Massara F; Cagliero E; Bisbocci D; Passarino G; Carta Q; Molinatti GM
    Diabete Metab; 1981 Sep; 7(3):149-53. PubMed ID: 7319114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatectomised man: A model for diabetes without glucagon.
    Barnes AJ; Bloom SR
    Lancet; 1976 Jan; 1(7953):219-21. PubMed ID: 55531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic effects of dopamine in man.
    Pernet A; Hammond VA; Blesa-Malpica G; Burrin J; Orskov H; Alberti KG; Johnston DG
    Eur J Clin Pharmacol; 1984; 26(1):23-8. PubMed ID: 6143668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin in maturity-onset diabetes.
    Christensen SE; Hansen AP; Lundbaek K
    Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics.
    Luyckx AS; Lefebvre PJ
    Diabetologia; 1976 Oct; 12(5):447-53. PubMed ID: 976635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
    Starke A; Keck E; Berger M; Zimmermann H
    Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.